The gut health and psoriasis connection is something most dermatologists don’t spend much time discussing. You go in with a skin problem. You leave with a cream, an ointment, or a prescription. The conversation rarely extends beyond the skin itself.
But research into what’s actually driving psoriasis has shifted significantly over the past decade — and what’s emerging is a picture in which the gut, the immune system, and the skin are far more interconnected than standard treatment approaches tend to acknowledge.
This doesn’t mean your psoriasis is a digestive problem. It means your immune system — which is the real driver of psoriasis — is deeply influenced by what’s happening in your gut. And understanding that connection gives you something useful: additional levers to pull alongside whatever treatment you’re already using.
Why the Gut and Skin Are Connected in the First Place
Your gut is home to trillions of bacteria, viruses, and fungi — collectively known as the gut microbiome. This community does far more than digest food. It actively trains and regulates your immune system, produces compounds that influence inflammation throughout the body, and maintains the integrity of the gut lining that separates its contents from your bloodstream.
The skin has its own microbial community too. And both communities communicate with your immune system constantly.
The connection between them — what researchers now call the gut-skin axis — is mediated primarily through the immune system. The association between inflammatory skin diseases and the gut microbiome is known to be mediated by dysfunctional intestinal barrier, increased inflammatory mediators, and metabolites released by microorganisms. MDPI
In practical terms, this means that when the gut microbiome is out of balance, the immune dysregulation that results doesn’t stay contained to the digestive system. It can show up in the skin — and in people with a genetic predisposition to psoriasis, that dysregulation can be exactly what tips a quiet immune system into an active one.
What the Research Has Found in Psoriasis Patients Specifically
People with psoriasis consistently show differences in their gut microbiome composition compared to people without it. Specifically, research has shown that the gut microbiome is often imbalanced in psoriasis patients, a condition known as dysbiosis, characterised by reduced microbial diversity and an imbalance in bacterial species.
More specifically, several patterns show up repeatedly across studies:
| What’s lower in psoriasis patients | What this affects |
|---|---|
| Lactobacillus species | Anti-inflammatory signalling, gut barrier integrity |
| Bifidobacterium species | Immune regulation, short-chain fatty acid production |
| Overall microbial diversity | Resilience of the immune environment |
| Faecalibacterium prausnitzii | One of the most important anti-inflammatory gut bacteria known |
These aren’t minor differences. Faecalibacterium prausnitzii in particular is considered one of the most important anti-inflammatory bacteria in the gut — it produces butyrate, a short-chain fatty acid that feeds the gut lining and actively dampens inflammatory signalling. Its consistent reduction in psoriasis patients is considered one of the more significant microbiome findings in this research area.
It’s worth noting that a careful 2025 study added important nuance here. Using a matched-pair approach, researchers found no evidence for depleted gut community diversity or apparent divergence in overall microbiome structure between psoriasis patients and healthy individuals — suggesting the relationship may be more subtle than earlier studies implied. The honest position is that the gut-psoriasis connection is real and meaningful, but not as simple as “psoriasis patients have a dramatically different microbiome.” The specific species-level shifts matter more than overall diversity scores.
Leaky Gut — The Bridge Between Your Gut and Your Skin
This is where the mechanism becomes most practically relevant.
The integrity of the intestinal barrier is a critical link between intestinal microbiota dysbiosis and the progression of psoriasis. Disruption of the intestinal barrier leads to leaky gut, allowing microorganisms, their metabolites, and antigens, which are normally confined to the intestinal lumen, to enter the bloodstream and skin. This triggers a systemic inflammatory response, destabilising skin homeostasis and potentially inducing or exacerbating psoriasis. PubMed Central
In plain language: your gut lining is supposed to act as a selective barrier, letting nutrients through while keeping bacteria, toxins, and undigested food particles on the inside. When that barrier becomes more permeable than it should be, these substances enter the bloodstream.
Patients with psoriasis typically exhibit increased intestinal permeability, with elevated serum levels of biomarkers such as Claudin-3, trimethylamine N-oxide, and intestinal fatty acid binding protein, all of which are associated with compromised intestinal barrier function. These biomarker levels are positively correlated with the severity of psoriasis. PubMed Central
This is a meaningful finding. It means leaky gut in psoriasis patients isn’t just a theoretical concern — it’s measurable through blood tests, and the degree of gut permeability correlates with how severe the psoriasis is. The worse the gut barrier function, the worse the skin disease tends to be.
Can Poor Gut Health Cause Skin Problems? Here’s What the Research Shows
The Inflammatory Bowel Disease Connection
One of the strongest pieces of evidence for the gut-psoriasis link comes not from microbiome research but from epidemiology — the study of who gets which conditions together.
People with inflammatory bowel disease — Crohn’s disease and ulcerative colitis — have a significantly higher rate of psoriasis than the general population. And the reverse is true too. Psoriasis patients have elevated rates of IBD.
This overlap isn’t coincidental. IBD is fundamentally a gut immune dysfunction condition, and psoriasis is fundamentally a skin immune dysfunction condition — and they share genetic risk factors, similar inflammatory pathways, and overlapping immune cell abnormalities.
| Condition | Psoriasis rate |
|---|---|
| General population | 2–3% |
| People with Crohn’s disease | 7–11% |
| People with ulcerative colitis | 3–5% |
The shared inflammatory pathways — particularly TNF-alpha and IL-17, which are the targets of modern biologic treatments — are active in both gut and skin inflammation. Some biologic medications approved for psoriasis are also approved for IBD, which is a direct reflection of this shared biology.
What Triggers Gut Dysbiosis That Might Worsen Psoriasis
Understanding what disturbs the gut microbiome in the first place helps explain why psoriasis can worsen with certain habits — even when those habits don’t seem skin-related.
Western diet patterns are among the strongest drivers of gut dysbiosis. A diet high in sugar and fat, typical of Western eating patterns, has been shown to disrupt gut microbiota and exacerbate psoriasis flares. These diets reduce microbial diversity, lower populations of anti-inflammatory bacteria like Faecalibacterium prausnitzii, and increase gut permeability — all of which connect to worsened psoriasis outcomes.
Antibiotics disrupt the gut microbiome significantly, and their effects can persist for months after a course of treatment. Frequent antibiotic use is associated with both increased risk of developing psoriasis and worsening of existing disease.
Chronic stress alters gut microbiome composition and increases gut permeability through the gut-brain axis — the same bidirectional communication system between the nervous system and the digestive tract. This provides a partial biological explanation for why stress is such a reliable psoriasis trigger.
Alcohol reduces populations of beneficial bacteria and increases gut permeability, which is consistent with its well-documented effect of worsening psoriasis severity.
Proton pump inhibitors — commonly used for acid reflux — alter gut pH in ways that shift microbiome composition, and their long-term use has been associated with reduced microbial diversity.
Can Improving Gut Health Help Psoriasis?
This is the practical question, and the honest answer is: for many people, yes — as part of a broader management approach, not as a standalone treatment.
Prebiotics, probiotics, synbiotics, dietary approaches, and fecal microbiota transplantation are being reviewed as supplementary and adjunctive therapies for psoriasis, with increasing evidence supporting their role alongside standard treatment.
The most consistently supportive dietary approach is the Mediterranean diet. An anti-inflammatory diet such as the Mediterranean diet, rich in fibre and low in inflammatory foods, may help manage psoriasis and its associated conditions. The Mediterranean diet supports microbiome diversity, maintains gut barrier integrity, and reduces the systemic inflammation that drives psoriasis plaques — all through the same mechanisms discussed in this article.
Specific things that support the gut-skin axis in psoriasis management:
| Approach | How it helps the gut-psoriasis connection |
|---|---|
| Probiotic supplementation (Lactobacillus, Bifidobacterium) | Restores beneficial bacterial populations reduced in psoriasis |
| High-fibre diet | Feeds butyrate-producing bacteria including Faecalibacterium prausnitzii |
| Fermented foods (yoghurt, kefir, sauerkraut) | Directly introduces beneficial bacteria and supports microbiome diversity |
| Reducing sugar and ultra-processed foods | Removes the primary dietary driver of dysbiosis |
| Omega-3 fatty acids | Reduces gut and systemic inflammation, supports barrier function |
| Reducing alcohol | Removes a significant gut barrier disruptor |
| Managing stress | Reduces gut permeability through the gut-brain axis |
None of these are quick fixes. The gut microbiome responds to consistent dietary patterns over weeks and months, not to occasional interventions. And none of them replace appropriate medical treatment for psoriasis — but as additions to treatment, they address an aspect of the condition that standard dermatological care rarely touches.
Probiotics for Psoriasis — What the Evidence Actually Shows
Probiotics deserve their own section because they’re among the most commonly asked-about gut-related interventions for psoriasis.
The evidence is real but measured. Clinical trials have generally shown modest but meaningful improvements in psoriasis severity scores with probiotic supplementation, particularly using Lactobacillus and Bifidobacterium strains. The improvements are not dramatic, and probiotics are not a treatment for psoriasis in any standalone sense.
What makes probiotics useful as an adjunct is the mechanism: they help restore the bacterial populations that are consistently reduced in psoriasis patients, reduce gut permeability, and produce short-chain fatty acids — particularly butyrate — that actively reduce inflammatory signalling throughout the body.
The most relevant strains in the psoriasis research are Lactobacillus acidophilus, Lactobacillus rhamnosus, and Bifidobacterium longum. Multi-strain formulas tend to outperform single-strain products in most microbiome research.
One clinical trial worth noting specifically tested probiotics alongside the psoriasis medication methotrexate in early-stage psoriasis patients, exploring whether microbiome modulation enhanced treatment response. This kind of combined approach — treating both the immune system and the gut environment simultaneously — is increasingly where psoriasis research is heading.
The Honest Picture
The gut-psoriasis connection is well-established in terms of association and mechanism — the two systems are clearly linked through shared immune pathways, gut barrier function, and bacterial metabolites.
What’s less settled is precisely how much the gut contributes to psoriasis severity in any individual case, how much improving gut health can shift outcomes, and which specific gut interventions produce the most reliable results. The 2025 matched-pair microbiome study mentioned earlier is a useful reminder that earlier research sometimes overstated the clarity of the dysbiosis picture — the reality is more nuanced than “psoriasis patients have a fundamentally different gut.”
What’s clear enough to act on is this: dietary patterns that support gut health — Mediterranean-style, high in fibre, fermented foods, omega-3s, and low in processed food and alcohol — consistently show up in the research as beneficial for psoriasis outcomes. The mechanism goes through the gut. Whether you think of it as gut treatment or anti-inflammatory eating, the practical recommendation is the same.
The Bottom Line
Your gut and your skin are in constant communication through shared immune pathways, inflammatory signals, and microbial metabolites. In psoriasis — a condition driven by immune dysfunction — the state of that gut-immune relationship matters.
Addressing gut health doesn’t cure psoriasis. But for many people, it reduces the frequency and severity of flares in ways that skin-focused treatment alone doesn’t fully achieve. It’s one more lever to pull — and given the practical steps involved (eating more fibre and fermented foods, reducing processed food and alcohol, managing stress), the barrier to trying it is very low relative to the potential benefit.
This article is for informational purposes only and does not constitute medical advice. Psoriasis is a medical condition that should be managed under the supervision of a qualified dermatologist or healthcare professional. Do not stop or change prescribed treatment without medical guidance.